• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

抗HIV肽T22的构效关系

Structure-activity relationships of an anti-HIV peptide, T22.

作者信息

Tamamura H, Murakami T, Masuda M, Otaka A, Takada W, Ibuka T, Nakashima H, Waki M, Matsumoto A, Yamamoto N

机构信息

Faculty of Pharmaceutical Sciences, Kyoto University, Japan.

出版信息

Biochem Biophys Res Commun. 1994 Dec 30;205(3):1729-35. doi: 10.1006/bbrc.1994.2868.

DOI:10.1006/bbrc.1994.2868
PMID:7811258
Abstract

T22 ([Tyr5,12,Lys7]-polyphemusin II) has been shown to have a strong anti-human immunodeficiency virus (HIV) activity comparable to that of 3'-azido-2',3'-dideoxythymidine (AZT). We studied the structure-anti-HIV activity relationships of T22 and determined the following information. The number of Arg residues in the N-terminal and C-terminal regions of T22 is closely related with anti-HIV activity. Disulfide rings, especially the major disulfide ring, are indispensable for anti-HIV activity and maintenance of the secondary structure. Between two repeats of Tyr-Arg-Lys, which are a characteristic structure contained in T22, Tyr-Arg-Lys in the N-terminal portion is more closely related with anti-HIV activity. We found some compounds having a higher selectivity index (50% cytotoxic concentration/50% effective concentration) than that of T22.

摘要

T22([酪氨酸5,12,赖氨酸7] - 海胆精蛋白II)已被证明具有强大的抗人类免疫缺陷病毒(HIV)活性,与3'-叠氮-2',3'-双脱氧胸苷(AZT)相当。我们研究了T22的结构与抗HIV活性之间的关系,并确定了以下信息。T22 N端和C端区域中精氨酸(Arg)残基的数量与抗HIV活性密切相关。二硫键环,尤其是主要的二硫键环,对于抗HIV活性和二级结构的维持是必不可少的。在T22特有的两个酪氨酸-精氨酸-赖氨酸重复序列之间,N端部分的酪氨酸-精氨酸-赖氨酸与抗HIV活性的关系更为密切。我们发现了一些化合物,其选择性指数(50%细胞毒性浓度/50%有效浓度)高于T22。

相似文献

1
Structure-activity relationships of an anti-HIV peptide, T22.抗HIV肽T22的构效关系
Biochem Biophys Res Commun. 1994 Dec 30;205(3):1729-35. doi: 10.1006/bbrc.1994.2868.
2
Pharmacophore identification of a chemokine receptor (CXCR4) antagonist, T22 ([Tyr(5,12),Lys7]-polyphemusin II), which specifically blocks T cell-line-tropic HIV-1 infection.趋化因子受体(CXCR4)拮抗剂T22([酪氨酸(5,12),赖氨酸7] - 多聚半胱氨酸II)的药效团鉴定,该拮抗剂可特异性阻断T细胞系嗜性HIV-1感染。
Bioorg Med Chem. 1998 Jul;6(7):1033-41. doi: 10.1016/s0968-0896(98)00061-3.
3
Downsizing of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II), with the maintenance of anti-HIV activity and solution structure.一种HIV细胞融合抑制剂T22([酪氨酸5,12,赖氨酸7] - 海胆精蛋白II)的缩微化,同时保持抗HIV活性和溶液结构。
Bioorg Med Chem. 1998 Apr;6(4):473-9. doi: 10.1016/s0968-0896(97)10055-4.
4
Molecular parameters for the anti-human immunodeficiency virus activity of T22 ([Tyr5,12, Lys7]-polyphemusin II).T22([酪氨酸5,12,赖氨酸7] - 海螯虾抗菌肽II)抗人类免疫缺陷病毒活性的分子参数
Biol Pharm Bull. 1994 Dec;17(12):1669-72. doi: 10.1248/bpb.17.1669.
5
Effective lowly cytotoxic analogs of an HIV-cell fusion inhibitor, T22 ([Tyr5,12, Lys7]-polyphemusin II).一种HIV细胞融合抑制剂T22([酪氨酸5,12,赖氨酸7] - 海螯虾抗菌肽II)的高效低细胞毒性类似物
Bioorg Med Chem. 1998 Feb;6(2):231-8. doi: 10.1016/s0968-0896(97)10037-2.
6
A novel anti-HIV synthetic peptide, T-22 ([Tyr5,12,Lys7]-polyphemusin II).一种新型抗HIV合成肽,T-22([酪氨酸5,12,赖氨酸7] - 多聚半胱氨酸II)
Biochem Biophys Res Commun. 1992 Dec 15;189(2):845-50. doi: 10.1016/0006-291x(92)92280-b.
7
Anti-human immunodeficiency virus activity of a novel synthetic peptide, T22 ([Tyr-5,12, Lys-7]polyphemusin II): a possible inhibitor of virus-cell fusion.新型合成肽T22([酪氨酸-5,12,赖氨酸-7]海胆精蛋白II)的抗人免疫缺陷病毒活性:一种可能的病毒-细胞融合抑制剂。
Antimicrob Agents Chemother. 1992 Jun;36(6):1249-55. doi: 10.1128/AAC.36.6.1249.
8
An anti-HIV peptide, T22, forms a highly active complex with Zn(II).一种抗HIV肽T22与锌(II)形成一种高活性复合物。
Biochem Biophys Res Commun. 1996 Dec 13;229(2):648-52. doi: 10.1006/bbrc.1996.1858.
9
The synthetic [Tyr5,12,Lys7]-polyphemusin II peptide (T22) binds to the CD4 cell surface molecule.合成的[酪氨酸5,12,赖氨酸7] - 海胆精蛋白II肽(T22)与CD4细胞表面分子结合。
Biochem Biophys Res Commun. 1995 Oct 13;215(2):626-31. doi: 10.1006/bbrc.1995.2510.
10
A comparative study of the solution structures of tachyplesin I and a novel anti-HIV synthetic peptide, T22 ([Tyr5,12, Lys7]-polyphemusin II), determined by nuclear magnetic resonance.通过核磁共振对鲎素I和一种新型抗HIV合成肽T22([酪氨酸5,12,赖氨酸7] - 海胆精蛋白II)的溶液结构进行的比较研究。
Biochim Biophys Acta. 1993 May 13;1163(2):209-16. doi: 10.1016/0167-4838(93)90183-r.

引用本文的文献

1
Targeting CXCR4 and CD47 Receptors: An Overview of New and Old Molecules for a Biological Personalized Anticancer Therapy.靶向 CXCR4 和 CD47 受体:生物个体化抗癌治疗的新老分子概述。
Int J Mol Sci. 2022 Oct 18;23(20):12499. doi: 10.3390/ijms232012499.
2
Antiviral Effects of Animal Toxins: Is There a Way to Drugs?动物毒素的抗病毒作用:是否有药物研发的可能?
Int J Mol Sci. 2022 Mar 26;23(7):3634. doi: 10.3390/ijms23073634.
3
Challenges and future prospects of antibiotic therapy: from peptides to phages utilization.抗生素治疗的挑战与未来前景:从肽类到噬菌体的应用
Front Pharmacol. 2014 May 13;5:105. doi: 10.3389/fphar.2014.00105. eCollection 2014.
4
Therapeutic approaches using host defence peptides to tackle herpes virus infections.利用宿主防御肽治疗疱疹病毒感染的方法。
Viruses. 2009 Dec;1(3):939-64. doi: 10.3390/v1030939. Epub 2009 Nov 18.
5
HIV entry inhibitors and their potential in HIV therapy.HIV进入抑制剂及其在HIV治疗中的潜力。
Med Res Rev. 2009 Mar;29(2):369-93. doi: 10.1002/med.20138.
6
Peptide antimicrobial agents.肽类抗菌剂。
Clin Microbiol Rev. 2006 Jul;19(3):491-511. doi: 10.1128/CMR.00056-05.
7
Inhibitory activity of synthetic peptide antibiotics on feline immunodeficiency virus infectivity in vitro.合成肽抗生素对猫免疫缺陷病毒体外感染性的抑制活性。
J Virol. 2002 Oct;76(19):9952-61. doi: 10.1128/jvi.76.19.9952-9961.2002.
8
Inhibitory mechanism of the CXCR4 antagonist T22 against human immunodeficiency virus type 1 infection.CXCR4拮抗剂T22对1型人类免疫缺陷病毒感染的抑制机制
J Virol. 1999 Sep;73(9):7489-96. doi: 10.1128/JVI.73.9.7489-7496.1999.
9
T134, a small-molecule CXCR4 inhibitor, has no cross-drug resistance with AMD3100, a CXCR4 antagonist with a different structure.T134是一种小分子CXCR4抑制剂,与结构不同的CXCR4拮抗剂AMD3100不存在交叉耐药性。
J Virol. 1999 Feb;73(2):1719-23. doi: 10.1128/JVI.73.2.1719-1723.1999.
10
A small molecule CXCR4 inhibitor that blocks T cell line-tropic HIV-1 infection.一种可阻断T细胞系嗜性HIV-1感染的小分子CXCR4抑制剂。
J Exp Med. 1997 Oct 20;186(8):1389-93. doi: 10.1084/jem.186.8.1389.